HLA class I-associated diseases with a suspected autoimmune etiology: HLA-B27 subtypes as a model system

European Journal of Cell Biology

Volumn 91, Issue 4, 2012, Pages 274-286

  Uchanska Ziegler, Barbara ^a   Loll, Bernhard ^b   Fabian, Heinz ^c   Hee, Chee Seng ^a   Saenger, Wolfram ^b   Ziegler, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Ankylosing Spondylitis; Autoimmunity; Heavy chain flexibility; HLA B27 subtypes; Infrared spectroscopy; Micropolymorphisms; Multiple Sclerosis; Peptide binding modes; T cell selection; X ray crystallography

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN;

ALLELE; ANKYLOSING SPONDYLITIS; ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CYTOTOXIC T LYMPHOCYTE; DIFFERENTIAL SCANNING CALORIMETRY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; INFRARED SPECTROSCOPY; MEDULLA OBLONGATA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; REACTIVE ARTHRITIS; SHORT SURVEY; SPONDYLOARTHROPATHY; T LYMPHOCYTE; THERMODYNAMICS; THYMUS; X RAY CRYSTALLOGRAPHY;

AUTOIMMUNE DISEASES; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HUMANS; MODELS, IMMUNOLOGICAL; PROTEIN STRUCTURE, TERTIARY; T-LYMPHOCYTE SUBSETS;

EID: 84855809682     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2011.03.003     Document Type: Short Survey

References (138)

1. Anaya J.-M. The autoimmune tautology. Arthritis Res. Ther. 2010, 12:147.
2. Anon. 3D presentation of structural and image data. J. Biol. Chem. 2009, 284:21101.
3. Australo-Anglo-American Spondyloarthritis Consortium (TASC), Reveille J.D., Sims A.M., Danoy P., Evans D.M., Leo P., Pointon J.J., Jin R., Zhou X., Bradbury L.A., Appleton L.H., Davis J.C., Diekman L., Doan T., Dowling A., Duan R., Duncan E.L., Farrar C., Hadler J., Harvey D., Karaderi T., Mogg R., Pomeroy E., Pryce K., Taylor J., Savage L., Deloukas P., Kumanduri V., Peltonen L., Ring S.M., Whittaker P., Glazov E., Thomas G.P., Maksymowych W.P., Inman R.D., Ward M.M., Stone M.A., Weisman M.H., Wordsworth B.P., Brown M.A. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 2010, 42:123-127.
4. Beltrami A., Rossmann M., Fiorillo M.T., Paladini F., Sorrentino R., Saenger W., Kumar P., Ziegler A., Uchanska-Ziegler B. Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes. J. Biol. Chem. 2008, 283:27189-27199.
5. Benjamin R.J., Madrigal J.A., Parham P. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature 1991, 351:74-77.
6. Bhatia K., Richens J., Prasad M.L., Koki G. High prevalence of the haplotype HLA-A11. B27 in arthritis patients from the highlands of Papua New Guinea. Tissue Antigens 1988, 31:103-106.
7. Blicher T., Kastrup J.S., Buus S., Gajhede M. High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsid peptide. Acta Crystallogr. D 2005, 61:1031-1040.
8. Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., Sturrock R.D. Ankylosing spondylitis and HLA-B27. Lancet 1973, 1:904-907.
9. Burfoot R.K., Jensen C.J., Field J., Stankovich J., Varney M.D., Johnson L.J., Butzkueven H., Booth D., Bahlo M., Tait B.D., Taylor B.V., Speed T.P., Heard R., Stewart G.J., Foote S.J., Kilpatrick T.J., Rubio J.P. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 2008, 71:42-50.
10. Chames P., Hufton S.E., Coulie P.G., Uchanska-Ziegler B., Hoogenboom H.R. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:7969-7974.
11. Cheung W., Ren E.C., Chan S.H., Gong W.K., Yap H.K. Increased HLA-A*11 in Chinese children with steroid-responsive nephrotic syndrome. Pediatr. Nephrol. 2002, 17:212-216.
12. Crites T.J., Varma R. On the issue of peptide recognition in T cell development. Self/Nonself 2010, 1:55-61.
13. D'Amato M., Fiorillo M.T., Carcassi C., Mathieu A., Zuccarelli A., Bitti P.P., Tosi R., Sorrentino R. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 1995, 25:3199-3201.
14. Dangoria N.S., DeLay M., Kingsbury D.J., Mear J.P., Uchanska-Ziegler B., Ziegler A., Colbert R.A. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J. Biol. Chem. 2002, 277:23459-23468.
15. Díaz-Peña R., Blanco-Gelaz M.A., Njobvu P., López-Vazquez A., Suárez-Alvarez B., López-Larrea C. Influence of HLA-B*5703 and HLA-B*1403 on susceptibility to spondyloarthropathies in the Zambian population. J. Rheumatol. 2008, 35:2236-2240.
16. Ehlers A., Beck S., Forbes S., Trowsdale J., Volz A., Younger R., Ziegler A. MHC-linked olfactory receptor loci exhibit polymorphism and contribute to extended HLA/OR haplotypes. Genome Res. 2000, 10:1968-1978.
17. Fabian H., Huser H., Narzi D., Misselwitz R., Loll B., Ziegler A., Böckmann R.A., Uchanska-Ziegler B., Naumann D. HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution. J. Mol. Biol. 2008, 376:798-810.
18. Fabian H., Huser H., Loll B., Ziegler A., Naumann D., Uchanska-Ziegler B. HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility. Arthritis Rheum. 2010, 62:978-987.
19. Fabian, H., Loll, B., Huser, H., Uchanska-Ziegler, B., Naumann, D., Ziegler, A. Influence of inflammation-related changes on conformational characteristics of HLA-B27 subtypes as detected by IR spectroscopy. FEBS J.,in press 2011.
20. Fahnestock M.L., Tamir I., Narhi L., Bjorkman P.J. Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule. Science 1992, 258:1658-1662.
21. Farid N.R., Moens H., Larsen B., Payne R., Saltman K., Fifield F., Ingram D.W. HLA haplotypes in familial Graves' disease. Tissue Antigens 1980, 15:492-500.
22. Fernando M.M.A., Stevens C.R., Walsh E.C., De Jager P.L., Goyette P., Plenge R.M., Vyse T.J., Rioux J.D. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008, 4:e1000024.
23. Fiorillo M.T., Maragno M., Butler R., Dupuis M.L., Sorrentino R. CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J. Clin. Invest. 2000, 106:47-53.
24. Fiorillo M.T., Rückert C., Hülsmeyer M., Sorrentino R., Saenger W., Ziegler A., Uchanska-Ziegler B. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J. Biol. Chem. 2005, 280:2962-2971.
25. Fiorillo M.T., Sorrentino R. T-cell responses against viral and self-epitopes and HLA-B27 subtypes differentially associated with ankylosing spondylitis. Adv. Exp. Med. Biol. 2009, 649:255-262.
26. Fogdell-Hahn A., Ligers A., Grønning M., Hillert J., Olerup O. Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 2000, 55:140-148.
27. Friese M.A., Jakobsen K.B., Friis L., Etzensperger R., Craner M.J., McMahon R.M., Jensen L.T., Huygelen V., Jones Y.E., Bell J.I., Fugger L. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat. Med. 2008, 14:1227-1235.
28. Galocha B., López de Castro J.A. Mutational analysis reveals a complex interplay of peptide binding and multiple biological features of HLA-B27. J. Biol. Chem. 2010, 285:39180-39190.
29. Garboczi D.N., Hung D.T., Wiley D.C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:3429-3433.
30. Goddard C.A., Butts D.A., Shatz C.J. Regulation of CNS synapses by neuronal MHC class I. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:6828-6833.
31. György B., Toth E., Tarcsa E., Falus A., Buzas E.I. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 2006, 38:1662-1677.
32. Harbo H.F., Lie B.A., Sawcer S., Celius E.G., Dai K.Z., Oturai A., Hillert J., Lorentzen A.R., Laaksonen M., Myhr K.M., Ryder L.P., Fredrikson S., Nyland H., Sørensen P.S., Sandberg-Wollheim M., Andersen O., Svejgaard A., Edland A., Mellgren S.I., Compston A., Vartdal F., Spurkland A. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004, 63:237-247.
33. Hee C.S., Gao S., Miller M.M., Goto R., Ziegler A., Daumke O., Uchanska-Ziegler B. Expression, purification and preliminary X-ray crystallographic analysis of the chicken MHC class I molecule YF1*7.1. Acta Cryst. F 2009, 65:422-425.
34. Hee C.S., Gao S., Loll B., Miller M.M., Uchanska-Ziegler B., Daumke O., Ziegler A. Structure of a classical MHC class I molecule that binds "non-classical" ligands. PLoS Biol. 2010, 8:e1000557.
35. Heinrichs H., Wernet P., Ziegler A. Expression of major histocompatibility antigens on human thymocytes studied using monoclonal antibodies. Immunogenetics 1980, 11:629-635.
36. *0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene. J. Mol. Biol. 2001, 310:1167-1176.
37. Hillig R.C., Hülsmeyer M., Welfle K., Misselwitz R., Welfle H., Saenger W., Kozerski C., Volz A., Uchanska-Ziegler B., Ziegler A. Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J. Biol. Chem. 2004, 279:652-663.
38. Hodis E., Sussman J.L. An encyclopedic effort to make 3D structures easier to understand. Trends Biochem. Sci. 2009, 34:100-101.
39. Hogquist K.A., Xing Y. Why CD8+ T cells need diversity when growing up. Immunity 2010, 32:5-6.
40. Horton R., Wilming L., Rand V., Lovering R.C., Bruford E.A., Khodiyar V.K., Lush M.J., Povey S., Talbot C.C., Wright M.W., Wain H.M., Trowsdale J., Ziegler A., Beck S. Gene map of the extended human MHC. Nat. Rev. Genet. 2004, 5:889-899.
41. Huh G.S., Boulanger L.M., Du H., Riquelme P.A., Brotz T.M., Shatz C.J. Functional requirement for class I MHC in CNS development and plasticity. Science 2000, 290:2155-2159.
42. Hülsmeyer M., Hillig R.C., Volz A., Rühl M., Schröder W., Saenger W., Ziegler A., Uchanska-Ziegler B. HLA-B27 subtypes differentially associated with disease exhibit subtle structural alterations. J. Biol. Chem. 2002, 277:47844-47853.
43. Hülsmeyer M., Fiorillo M.T., Bettosini F., Sorrentino R., Saenger W., Ziegler A., Uchanska-Ziegler B. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J. Exp. Med. 2004, 199:271-281.
44. Hülsmeyer M., Chames P., Hillig R.C., Stanfield R.L., Held G., Coulie P.G., Alings C., Wille G., Saenger W., Uchanska-Ziegler B., Hoogenboom H.R., Ziegler A. A major histocompatibility complex:peptide-restricted antibody and T cell receptor molecules recognize their target by distinct binding modes. Crystal structure of human leukocyte antigen (HLA)-A1:MAGE-A1 in complex with Fab-Hyb3. J. Biol. Chem. 2005, 280:2972-2980.
45. Hülsmeyer M., Welfle K., Pöhlmann T., Misselwitz R., Alexiev U., Welfle H., Saenger W., Uchanska-Ziegler B., Ziegler A. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide. J. Mol. Biol. 2005, 346:1367-1379.
46. Huseby E.S., Kappler J.W., Marrack P. Thymic selection stifles TCR reactivity with the main chain structure of MHC and forces interactions with the peptide side chains. Mol. Immunol. 2008, 45:599-606.
47. Kelley J., Walter L., Trowsdale J. Comparative genomics of major histocompatibility complexes. Immunogenetics 2005, 56:683-695.
48. Kim M.H., Seong M.C., Kwak N.H., Yoo J.S., Huh W., Kim T.G., Han H. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am. J. Ophthalmol. 2000, 129:173-177.
49. Klein L., Hinterberger M., Wirnsberger G., Kyewski B. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat. Rev. Immunol. 2009, 9:833-844.
50. Koch M., Camp S., Collen T., Avila D., Salomonsen J., Wallny H.J., van Hateren A., Hunt L., Jacob J.P., Johnston F., Marston D.A., Shaw I., Dunbar P.R., Cerundolo V., Jones E.Y., Kaufman J. Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity 2007, 27:885-899.
51. Košmrlj A., Read E.L., Qi Y., Allen T.M., Altfeld M., Deeks S.G., Pereyra F., Carrington M., Walker B.D., Chakraborty A.K. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature 2010, 465:350-354.
52. Kumar P., Vahedi-Farid A., Merino E., López de Castro J.A., Volz A., Ziegler A., Saenger W., Uchanska-Ziegler B. Expression, purification and preliminary X-ray crystallographic analysis of the human major histocompatibility antigen HLA-B*1402 in complex with a viral and with a self-peptide. Acta Cryst. F 2007, 63:631-634.
53. Kumar P., Ziegler A., Ziegler J., Uchanska-Ziegler B., Ziegler A. Grasping molecular structures through publication-integrated 3D models. Trends Biochem. Sci. 2008, 33:408-412.
54. Kumar P., Vahedi-Faridi A., Saenger W., Merino E., López de Castro J.A., Uchanska-Ziegler B., Ziegler A. Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens. J. Biol. Chem. 2009, 284:29784-29797.
55. Kumar P., Vahedi-Faridi A., Saenger W., Ziegler A., Uchanska-Ziegler B. Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity. Prot. Sci. 2009, 18:37-49.
56. Kumar P., Ziegler A., Grahn A., Hee C.S., Ziegler A. Leaving the structural ivory tower, assisted by 3D PDF. Trends Biochem. Sci. 2010, 35:419-422.
57. Laun K., Coggill P., Palmer S., Sims S., Ning Z., Ragoussis J., Volpi E., Wilson N., Beck S., Ziegler A., Volz A. The leukocyte receptor complex in chicken is characterized by massive expansion and diversification of immunoglobulin-like loci. PLoS Genet. 2006, 2:707-718.
58. Li L., Bouvier M. Structures of HLA-A*1101 complexed with immunodominant nonamer and decamer HIV-1 epitopes clearly reveal the presence of a middle, secondary anchor residue. J. Immunol. 2004, 172:6175-6184.
59. Li L., Chen W., Bouvier M. A biochemical and structural analysis of genetic diversity within the HLA-A*11 subtype. Immunogenetics 2005, 57:315-325.
60. Loll B., Zawacka A., Biesiadka J., Petter C., Rückert C., Saenger W., Uchanska-Ziegler B., Ziegler A. Preliminary X-ray diffraction analysis of crystals from the recombinantly expressed human major histocompatibility antigen HLA-B*2704 in complex with a viral peptide and with a self-peptide. Acta Cryst. F 2004, 61:939-941.
61. Loll B., Rückert C., Hee C.S., Saenger W., Uchanska-Ziegler B., Ziegler A. Loss of recognition by cross-reactive T cells and its relation to C-terminus-induced conformational reorientation of an HLA-B*2705-bound peptide. Prot. Sci. 2011, 20:278-290.
62. López de Castro J.A. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens 2007, 71:495-506.
63. López de Castro J.A., Alvarez I., Marcilla M., Paradela A., Ramos M., Sesma L., Vázquez M. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 2004, 63:424-445.
64. *1403 in a West African population. Arthritis Rheum. 2002, 46:2968-2971.
65. López-Larrea C., Díaz-Peña R. Molecular Mechanisms of Spondyloarthropathies 2009, Landes Bioscience, Austin.
66. Madden D.R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 1995, 13:587-622.
67. Madden D.R., Gorga J.C., Strominger J.L., Wiley D.C. The three-dimensional structure of HLA-B27 at 2.1A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992, 70:1035-1048.
68. Makhatadze N.J., Sanches-Llamozas P., Franco M.T., Layrisse Z. Strong association between major histocompatibility complex class I antigens and immune aberrations among healthy Venezuelans. Hum. Immunol. 1995, 42:189-194.
69. Makrygiannakis D., Af Klint E., Lundberg I.E., Löfberg R., Ulfgren A.K., Klareskog L., Catrina A.I. Citrullination is an inflammation-dependent process. Ann. Rheum. Dis. 2006, 65:1219-1222.
70. Malfroy L., Roth M., Borot N., Carrington M., Volz A., Ziegler A., Coppin H. Heterogeneity in rates of recombination in the 6 Mb region telomeric to the human major histocompatibility complex. Genomics 1997, 43:226-231.
71. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today. 1998, 19:395-404.
72. McCallum H. Tasmanian devil facial tumour disease: lessons for conservation biology. Trends Ecol. Evol. 2008, 23:631-637.
73. McConnell M.J., Huang Y.H., Datwani A., Shatz C.J. H2-Kb and H2-Db regulate cerebellar long-term depression and limit motor learning. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6784-6789.
74. *3501 due to nonstandard positioning of the C-terminus. J. Mol. Biol. 1999, 285:645-653.
75. Milinski M. The major histocompatibility complex, sexual selection and mate choice. Annu. Rev. Ecol. Evol. Syst. 2006, 37:159-186.
76. Morsy T.A., Romia S.A., Al-Ganayni G.A., Abu-Zakham A.A., Al-Shazly A.M., Rezk R.A. Histocompatibility (HLA) antigens in Egyptians with two parasitic skin diseases (scabies and leishmaniasis). J. Egypt Soc. Parasitol. 1990, 20:565-572.
77. Müller C., Stein H., Ziegler A., Wernet P. Quantitative and qualitative differences in the distribution of HLA class I antigenic determinants in the human thymic compartments. Eur. J. Immunol. 1983, 13:414-418.
78. Murata S., Sasaki K., Kishimoto T., Niwa S., Hayashi H., Takahama Y., Tanaka K. Regulation of CD8+ T cell development by thymus-specific proteasomes. Science 2007, 316:1349-1353.
79. Nakada M., Nakada K., Kawaguchi F., Wakisaka M., Kashimura T., Yamate N., Maeyama S., Uchikoshi T. Immunologic reaction and genetic factors in biliary atresia. Tohoku J. Exp. Med. 1997, 181:41-47.
80. Narzi D., Winkler K., Saidowsky J., Misselwitz R., Ziegler A., Böckmann R.A., Alexiev U. Molecular determinants of major histocompatibility complex class I complex stability: shaping antigenic features through short range and long range electrostatic interactions. J. Biol. Chem. 2008, 283:23093-23103.
81. Nossal G.J. Negative selection of lymphocytes. Cell 1994, 76:229-239.
82. Nowak M.A., Tarczy-Hornoch K., Austyn J.M. The optimal number of major histocompatibility complex molecules in an individual. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:10896-10899.
83. O'Hanlon T.P., Carrick D.M., Arnett F.C., Reveille J.D., Carrington M., Gao X., Oddis C.V., Morel P.A., Malley J.D., Malley K., Dreyfuss J., Shamim E.A., Rider L.G., Chanock S.J., Foster C.B., Bunch T., Plotz P.H., Love L.A., Miller F.W. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians. Medicine (Baltimore) 2005, 84:338-349.
84. Park M.H., Kim Y.W., Yoon H.I., Yoo C.G., Han S.K., Shim Y.S., Kim W.D. Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients. Am. J. Respir. Crit. Care Med. 1999, 159:526-529.
85. Penn D., Potts W.K. How do major histocompatibility complex genes influence odor and mating preferences?. Adv. Immunol. 1998, 69:411-436.
86. Piertney S.B., Oliver M.K. The evolutionary ecology of the major histocompatibility complex. Heredity 2006, 96:7-21.
87. Pöhlmann T., Böckmann R.A., Grubmüller H., Uchanska-Ziegler B., Ziegler A., Alexiev U. Differential peptide dynamics is linked to MHC polymorphism. J. Biol. Chem. 2004, 279:28197-28201.
88. Reche P.A., Reinherz E.L. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J. Mol. Biol. 2003, 331:623-641.
89. Reche P.A., Zhang H., Glutting J.P., Reinherz E.L. EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology. Bioinformatics 2005, 21:2140-2141.
90. Rehm A., Rohr A., Seitz C., Wonigeit K., Ziegler A., Uchanska-Ziegler B. Structurally diverse forms of HLA-B27 molecules are displayed in vivo in a cell type-dependent manner. Hum. Immunol. 2000, 61:408-418.
91. Ribic A., Zhang M., Schlumbohm C., Mätz-Rensing K., Uchanska-Ziegler B., Flügge G., Zhang W., Walter L., Fuchs E. Neuronal MHC class I molecules are involved in excitatory synaptic transmission at the hippocampal mossy fiber synapses of marmoset monkeys. Cell. Mol. Neurobiol. 2010, 30:827-839.
92. Rölleke U., Flügge G., Plehm S., Schlumbohm C., Armstrong V.W., Dressel R., Uchanska-Ziegler B., Ziegler A., Fuchs E., Czéh B., Walter L. Differential expression of major histocompatibility complex class I molecules in the brain of a New World monkey, the common marmoset (Callithrix jacchus). J. Neuroimmunol. 2006, 176:39-50.
93. Rückert C., Fiorillo M.T., Loll B., Moretti R., Biesiadka J., Saenger W., Ziegler A., Sorrentino R., Uchanska-Ziegler B. Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLA-B27 subtype. J. Biol. Chem. 2006, 281:2306-2316.
94. Rudolph M.G., Stanfield R.L., Wilson I.A. How TCRs bind MHCs, peptides and coreceptors. Annu. Rev. Immunol. 2006, 24:419-466.
95. Santos P.S.C., Füst G., Prohászka Z., Volz A., Horton R., Miretti M., Yu C.-Y., Beck S., Uchanska-Ziegler B., Ziegler A. Association of smoking behavior with an odorant receptor allele telomeric to the human major histocompatibility complex. Genet. Test. 2008, 12:481-486.
96. Santos P.S.C., Uehara C.J.S., Ziegler A., Uchanska-Ziegler B., Bicalho M.G. Variation and linkage disequilibrium within odorant receptor gene clusters linked to the human major histocompatibility complex. Hum. Immunol. 2010, 71:843-850.
97. Schlosstein L., Terasaki P.I., Bluestone R., Pearson C.M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N. Engl. J. Med. 1973, 288:704-706.
98. Schumacher T.N., Ploegh H.L. Are MHC-bound peptides a nuisance for positive selection?. Immunity 1994, 1:721-723.
99. Siddle H.V., Kreiss A., Eldridge M.D.B., Noonan E., Clarke C.J., Pyecroft S., Woods G.M., Belov K. Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16221-16226.
100. Siddle H.V., Marzec J., Cheng Y., Jones M., Belov K. MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer. Proc. Biol. Sci. 2010, 277:2001-2006.
101. Silver M.L., Guo H.C., Strominger J.L., Wiley D.C. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 1992, 360:367-369.
102. Starr T.K., Jameson S.C., Hogquist K.A. Positive and negative selection of T cells. Annu. Rev. Immunol. 2003, 21:139-176.
103. *2705. Eur. J. Immunol. 2005, 35:341-351.
104. Sundick R.S., Bagchi N., Brown T.R. The obese strain chicken as a model for human Hashimoto's thyroiditis. Exp. Clin. Endocrinol. Diabetes 1996, 104(Suppl. 3):4-6.
105. Takahama Y., Nitta T., Mat Ripen A., Nitta S., Murata S., Tanaka K. Role of thymic cortex-specific self-peptides in positive selection of T cells. Semin. Immunol. 2010, 22:287-293.
106. Taurog J.D. Animal models of spondyloarthritis. Adv. Exp. Med. Biol. 2009, 649:245-254.
107. Taurog J.D. The role of HLA-B27 in spondyloarthritis. J. Rheumatol. 2010, 37:2006-2016.
108. Thomas G.P., Brown M.A. Genetics and genomics of ankylosing spondylitis. Immunol. Rev. 2010, 233:162-180.
109. Tran T.M., Dorris M.L., Satumtira N., Richardson J.A., Hammer R.E., Shang J., Taurog J.D. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum. 2006, 54:1317-1327.
110. Tsuchiya K., Kimura A., Kondo M., Nishimura Y., Sasazuki T. Combination of HLA-A and HLA class II alleles controls the susceptibility to rheumatoid arthritis. Tissue Antigens 2001, 58:395-401.
111. Tyzack J.K. Dragging (and zooming and rotating) publication of 3D molecular structures into the 21st century. Trends Biochem. Sci. 2008, 33:405-407.
112. 2m-deposition disease?. Trends Immunol. 2003, 24:73-76.
113. 2m-deposition disease?. Trends Immunol. 2003, 24:229-230.
114. Uchanska-Ziegler B., Ziegler A. On the reactivity of monoclonal antibodies specific for different forms of HLA class I molecules. Rheumatology (Oxford) 2007, 46:555-556.
115. Uchanska-Ziegler B., Ziegler A. HLA-B27 transgenic rats, amyloid deposits, and spondyloarthropathies. Mod. Rheumatol. 2008, 18:425-426.
116. *2709 molecules complexed with the same peptide. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Congress, vol. I 2006, 138-147. IHWG Press, Seattle, USA. J.A. Hansen (Ed.).
117. Urban R.G., Chicz R.M., Lane W.S., Strominger J.L., Rehm A., Kenter M.G.H., UytdeHaag F.G.C.M., Ploegh H.L., Uchanska-Ziegler B., Ziegler A. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:1534-1538.
118. von Boehmer H. Positive selection of lymphocytes. Cell 1994, 76:219-228.
119. von Boehmer H., Aifantis I., Gounari F., Azogui O., Haughn L., Apostolou I., Jaeckel E., Grassi F., Klein L. Thymic selection revisited: how essential is it?. Immunol. Rev. 2003, 191:62-78.
120. Wallny H.J., Avila D., Hunt L.G., Powell T.J., Riegert P., Salomonsen J., Skjødt K., Vainio O., Vilbois F., Wiles M.V., Kaufman J. Peptide motifs of the single dominantly expressed class I molecule explain the striking MHC determined response to Rous sarcoma virus in chickens. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1434-1439.
121. Winkler K., Winter A., Rueckert C., Uchanska-Ziegler B., Alexiev U. Natural MHC class I polymorphism controls the pathway of peptide dissociation from HLA-B27 complexes. Biophys. J. 2007, 93:2743-2755.
122. Woelfing B., Traulsen A., Milinski M., Boehm T. Does intra-individual major histocompatibility complex diversity keep a golden mean?. Phil. Trans. R. Soc. B 2009, 364:117-128.
123. *2706 in complex with a viral peptide and with a self-peptide. Acta Cryst. F 2005, 61:1097-1099.
124. Ziegler A. Biology of chromosome 6. DNA Sequence 1997, 8:189-202.
125. Ziegler A. Moleküle des MHC und olfaktorische Rezeptoren: Mögliche Bedeutung im Rahmen der Reproduktion. J. Fertil. Reprod. 2003, 13:14-18.
126. Ziegler A., Pink J.R.L. Chemical properties of two antigens controlled by the major histocompatibility complex of the chicken. J. Biol. Chem. 1976, 251:5391-5396.
127. Ziegler A., Ehlers A., Forbes S., Trowsdale J., Uchanska-Ziegler B., Volz A., Younger R., Beck S. Polymorphic olfactory receptor genes and HLA loci constitute extended haplotypes. Major Histocompatibility Complex - Evolution, Structure, and Function 2000, 110-130. Springer Verlag, Tokyo. M. Kasahara (Ed.).
128. Ziegler A., Dohr G., Uchanska-Ziegler B. Possible roles for products of polymorphic MHC and linked olfactory receptor genes during selection processes in reproduction. Am. J. Reprod. Immunol. 2002, 48:34-42.
129. Ziegler A., Kentenich H., Uchanska-Ziegler B. Female choice and the MHC. Trends Immunol. 2005, 26:496-502.
130. Ziegler A., Dohr G., Kentenich H., Uchanska-Ziegler B. Self-nonself discrimination and reproductive performance. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Congress, vol. I 2006, 1534-1538. IHWG Press, Seattle, USA. J.A. Hansen (Ed.).
131. Ziegler A., Coulie P.G., Uchanska-Ziegler B. Monoclonal and recombinant antibodies with T cell receptor-like reactivity. Recent Results in Cancer Research - Targeted Therapies in Cancer 2007, vol. 176:229-242. Springer Verlag, Heidelberg.
132. Ziegler A., Faber C., Mueller S., Bartolomaeus T. Systematic comparison and reconstruction of sea urchin (Echinoidea) internal anatomy: a novel approach using magnetic resonance imaging. BMC Biol. 2008, 6:33.
133. Ziegler A., Müller C.A., Böckmann R.A., Uchanska-Ziegler B. Low-affinity peptides and T-cell selection. Trends Immunol. 2009, 30:53-60.
134. Ziegler A., Loll B., Misselwitz R., Uchanska-Ziegler B. Implications of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis. Adv. Exp. Med. Biol. 2009, 649:177-195.
135. Ziegler A., Santos P.S.C., Kellermann T., Uchanska-Ziegler B. Self/nonself perception, reproduction, and the extended MHC. Self/Nonself 2010, 1:176-191.
136. Ziegler A., Ogurreck M., Beckmann F., Steinke T., Prohaska S., Ziegler A. Opportunities and challenges for digital morphology. Biol. Direct 2010, 5:45.
137. Ziegler A., Mooi R., Rolet G., de Ridder C. Origin and evolutionary plasticity of the gastric caecum in sea urchins (Echinodermata: Echinoidea). BMC Evol. Biol. 2010, 10:313.
138. Ziegler A., Mietchen D., Faber C., von Hausen W., Schöbel C., Sellerer M., Ziegler A. Effectively incorporating selected multimedia content into medical publications. BMC Med. 2011, 9:17.